Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug,
scientific article published on 12 April 2018
Author/s
author: Piotr Rutkowski, Maria Debiec-Rychter, Patrick Schöffski, Raf Sciot, Hans J. Gelderblom, Axelle Nzokirantevye, Sandra J Strauss, Sandrine Marréaud, Sandra Collette, Jozef Sufliarsky, Lars Lindner
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.